Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Non Operating Income: 2024-2025

Historic Non Operating Income for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $1.5 million.

  • Pyxis Oncology's Non Operating Income fell 42.85% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year change of. This contributed to the annual value of $10.0 million for FY2024, which is 18.55% up from last year.
  • As of Q3 2025, Pyxis Oncology's Non Operating Income stood at $1.5 million, which was down 13.16% from $1.7 million recorded in Q2 2025.
  • Pyxis Oncology's Non Operating Income's 5-year high stood at $2.7 million during Q2 2024, with a 5-year trough of $1.5 million in Q3 2025.
  • Its 2-year average for Non Operating Income is $2.1 million, with a median of $2.3 million in 2024.
  • Data for Pyxis Oncology's Non Operating Income shows a maximum YoY crashed of 42.85% (in 2025) over the last 5 years.
  • Over the past 2 years, Pyxis Oncology's Non Operating Income (Quarterly) stood at $2.3 million in 2024, then tumbled by 42.85% to $1.5 million in 2025.
  • Its Non Operating Income was $1.5 million in Q3 2025, compared to $1.7 million in Q2 2025 and $1.8 million in Q1 2025.